Millennium sells Skelite to Medtronic units
This article was originally published in Clinica
Executive Summary
Troubled regenerative medicine company Millennium Biologix is to sell one of its core technologies, the Skelite resorbable synthetic bone graft, to two Medtronic subsidiaries, Medtronic of Canada and Warsaw Orthopedic in Indiana. Under the terms of the purchase agreement, Millennium will receive a closing payment, of which the amount was not disclosed, as well as the potential milestone and contingent fees.